MANUFACTURERS LIFE INSURANCE COMPANY, THE - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$265,212
-13.5%
20,850
-4.3%
0.00%
Q2 2023$306,634
-68.4%
21,778
-65.3%
0.00%
-100.0%
Q1 2023$970,801
-2.7%
62,835
+1.4%
0.00%0.0%
Q4 2022$997,977
-10.2%
61,964
-0.4%
0.00%0.0%
Q3 2022$1,111,804
+245.4%
62,192
+155.5%
0.00%
Q2 2022$321,869
+97.7%
24,340
+38.6%
0.00%
Q1 2022$162,846
-23.5%
17,567
-19.3%
0.00%
Q4 2021$213,000
-70.3%
21,767
+2.9%
0.00%
-100.0%
Q3 2021$718,000
-13.5%
21,144
-6.8%
0.00%0.0%
Q2 2021$830,000
-16.9%
22,681
+1.8%
0.00%0.0%
Q1 2021$999,000
-23.9%
22,280
-3.2%
0.00%0.0%
Q4 2020$1,313,000
+17.0%
23,011
+5.2%
0.00%0.0%
Q3 2020$1,122,000
-14.7%
21,868
-2.7%
0.00%0.0%
Q2 2020$1,316,000
+133.7%
22,486
+64.4%
0.00%0.0%
Q1 2020$563,000
-23.8%
13,677
+15.2%
0.00%0.0%
Q4 2019$739,000
+91.0%
11,873
-0.2%
0.00%
Q3 2019$387,000
+68.3%
11,898
+16.5%
0.00%
Q2 2019$230,000
-13.2%
10,210
+51.8%
0.00%
Q2 2018$265,000
+77.9%
6,726
-9.6%
0.00%
Q1 2018$149,000
-16.8%
7,441
-5.4%
0.00%
Q4 2017$179,0007,8630.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$69,030,00015.95%
SV Health Investors, LLC 449,951$25,679,00012.37%
Sunesis Advisors, LLC 96,299$5,496,0004.45%
Redmile Group, LLC 4,437,968$253,275,0003.07%
Consonance Capital Management LP 484,671$27,660,0002.58%
SECTORAL ASSET MANAGEMENT INC 488,842$27,898,0001.97%
Opaleye Management Inc. 222,000$12,670,0001.66%
Eversept Partners, LP 246,240$14,052,9171.65%
SILVERARC CAPITAL MANAGEMENT, LLC 38,620$2,204,0001.28%
Avoro Capital Advisors LLC 1,300,000$74,191,0001.28%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders